Sector: MedicalPfizer, Inc. (NYSE: PFE)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 189 |
Technical : | 20 |
Performance : | 199 |
Overall: | 134 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 201 |
Technical : | 55 |
Performance : | 209 |
Overall: | 166 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 201 |
Technical : | 9 |
Performance : | 223 |
Overall: | 150 |
Number of Stocks: | 305 |
Headlines
- Hamilton Thorne files second quarter results as part of qualifying transaction requirements
Nov 06, 2009 04:16 PM | CRL, DD, MON, MRK, NVS
- Graceway Pharmaceuticals Acquires Worldwide Rights to GS 9191 from Gilead Sciences
Nov 06, 2009 08:58 AM | GILD, PFE
- Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Nov 06, 2009 03:01 AM | PFE
- Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results
Nov 05, 2009 04:01 PM | FACT, PFE, TRBN
- Options Intellignece Report : Options Activity for XRT, CVS, STT, PFE, FSYS & AEO
Nov 05, 2009 03:17 PM | AEO, CVS, FSYS, PFE, STT
- Philanthropists, Medical Research Foundations, and Industry Leaders Gather in New York for Inaugural Partnering for Cures Meeting
Nov 05, 2009 11:11 AM | PFE
- Ligand's JAK3 Research Collaboration Extended by Pfizer
Nov 05, 2009 08:30 AM | LGND, PFE
- Icagen Reports Third Quarter 2009 Financial Results and Operational Highlights
Nov 05, 2009 08:16 AM | ICGN, PFE
- Widespread Generic Erosion of Atypical Antipsychotics Will Cause the Bipolar Disorder Drug Market to Decline By More Than $1 Billion Through 2018
Nov 05, 2009 08:03 AM | AZN, LLY, PFE
- Trading Outlook for Advanced Life Sciences Holdings Inc. Issued by InvestorSoup.com
Nov 05, 2009 06:51 AM | ADLS, GSK, JNJ, PFE
- Business Highlights
Nov 02, 2009 06:52 PM | BDK, CIT, HUM, MRK, PFE, SGP
- Lazard: Wasserstein stock leads to $86.5M charge
Oct 28, 2009 11:52 AM | PFE
- Lazard: Wasserstein options lead to $86.5M charge
Oct 28, 2009 10:53 AM | PFE
- Unilab, Pfizer Figure in 'Drug War'
Oct 28, 2009 01:51 AM | PFE
- Pfizer Sues Unilab Over Lipitor Drug
Oct 24, 2009 01:52 AM | IPR, PFE
- Bristol-Myers posts higher 3Q sales, lower profit
Oct 22, 2009 02:53 PM | MRK, PFE, SGP
- Eli Lilly CEO banking on new drug pipeline
Oct 22, 2009 01:54 PM | LLY, PFE
- Leading indicators signal growth, but jobs scarce
Oct 22, 2009 12:55 PM | PFE
- Pfizer Q3 Net Income Up 26%
Oct 22, 2009 01:51 AM | PFE
- Earnings Preview: Bristol-Myers 3Q earnings report
Oct 21, 2009 11:53 AM | AZN, BMY, GSK, JNJ, LLY, MRK
- Celldex Therapeutics Reports Third Quarter and Nine Month 2009 Financial Results
Nov 04, 2009 07:51 AM | PFE
- PicksThatMove.Com Announces Investment Opinion on TPS, ML, KOG, GAP and PFE
Oct 27, 2009 03:51 PM | KOG, PFE
- MichBio Expo &Amp; Conference Exhibitors Profiled
Oct 27, 2009 11:53 AM | ENL, PFE, TEVA
- Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Oct 27, 2009 07:53 AM | LGND, MBRX, PFE, SGP
- Mission Bay Capital Announces First Venture Fund
Oct 26, 2009 05:51 PM | PFE
- ArthroCare Names David Fitzgerald President and CEO
Oct 26, 2009 07:51 AM | KCI, PFE
- Cutting Edge Information Investigates Pfizer-Wyeth Merger, Studies Current M&Amp;A Drivers
Oct 22, 2009 09:53 AM | PFE
- Kansas City Business Journalist Announces American Innovation Tour
Oct 21, 2009 10:56 AM | HPQ, MMM, PFE
- Pfizer Reports Third-Quarter 2009 Results
Oct 20, 2009 07:53 AM | PFE, WYE
- Health Discovery Corporation Announces Additional Issued Patents and Notices of Allowance to Its Intellectual Property Portfolio
Oct 19, 2009 09:53 AM | ABT, CLRT, DGX, IART, PFE
- Form 4 Redmond Cavan M. For: Oct 30 (10K)
Nov 03, 2009 06:03 PM
- Form 4 Dolsten Mikael For: Oct 30 (10K)
Nov 03, 2009 06:03 PM
- Form 4 SUSMAN SALLY For: Oct 30 (10K)
Nov 03, 2009 05:21 PM
- Form 4 RINGO WILLIAM R For: Oct 30 (10K)
Nov 03, 2009 05:21 PM
- Form 4 PFIZER INC For: Oct 30 Filed by: RICCIARDI NATALE S (10K)
Nov 03, 2009 05:21 PM
- Form 4 READ IAN C For: Oct 30 (10K)
Nov 03, 2009 05:21 PM
- Form 4 MCLEOD MARY S For: Oct 30 (10K)
Nov 03, 2009 05:21 PM
- Form 4 MACKAY MARTIN For: Oct 30 (10K)
Nov 03, 2009 05:21 PM
- Form 4 Lewis-Hall Freda C For: Oct 30 (10K)
Nov 03, 2009 05:18 PM
- Form 4 DAMELIO FRANK A For: Oct 30 (10K)
Nov 03, 2009 05:18 PM
Analyst Ratings
Share Performance
|
Period
|
PFE
|
Compare to S&P
|
| YTD |
-3.84 %
|
-16.18 %
|
| 4 Weeks |
5.45 %
|
4.33 %
|
| 12 Weeks |
6.70 %
|
4.06 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 6.25 %
|
|
EPS Growth in Last Year: -17.74 %
|
|
Sales Growth in Last Quarter: 5.80 %
|
|
Sales Growth in Last Quarter: -2.94 %
|
|
